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SUMMARY – The Vibrant Soundbridge represents a new approach to hearing improvement in 
the form of active implantable middle ear hearing device. Unlike conventional acoustic hearing aids, 
which increase the volume of sound that goes to the eardrum, the Vibrant Soundbridge bypasses the 
ear canal and eardrum by directly vibrating the small bones in the middle ear. Because of its design, no 
portion of the device is placed in the ear canal itself. The Vibrant Soundbridge has been approved by 
the FDA as a safe and effective treatment option for adults with moderate to severe sensorineural, 
conductive or mixed hearing losses who desire an alternative to the acoustic hearing aids, for better 
hearing. The paper presents a review of the active middle ear implant Vibrant Soundbridge, which has 
been also implanted at the Department of Otorhinolaryngology and Head and Neck Surgery, Sestre 
milosrdnice University Hospital Center, which is the Referral Center for Cochlear Implantation and 
Surgery of Hearing Impairment and Deafness of the Ministry of Health, Republic of Croatia.
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Introduction
Middle ear implants (MEIs) are useful for those 
with a purely sensorineural hearing loss. Historically, 
the first clinically available MEIs (by Suzuki and 
Yanagihara in Japan) were those with unresolveable 
middle ear conductive/mixed losses1. However, mod-
ern MEIs require a well functioning ossicular chain. 
MEIs have been around in one form or another since 
1935 when Dr. Wilska sprinkled some iron filings 
onto a person’s eardrum. A magnetic field was gener-
ated by a coil of wire inside an earphone and was ap-
plied to the iron filings. The subjects reported ‘hearing’, 
despite the fact there was no acoustic sound energy 
coming from the earphone. The magnetic field from 
the earphone caused the iron filings to vibrate in syn-
chrony with the magnetic field. This vibration in turn 
caused the eardrum to vibrate, which allowed sound to 
be transduced to the inner ear in the normal fashion. 
Dr. Wilska’s experimental device had some obvious 
limitations, i.e. its bulky size, the amount of energy re-
quired to transduce a sound (28,000 mA to produce 85 
dB SPL) and the person had to be lying down on the 
bed in order to keep the iron filings correctly posi-
tioned on the tympanic membrane. Since the 1930s, a 
number of research teams around the world have tried 
to create a wearable MEI. Current MEIs can generate 
85 dB with less than 3 mA.
A MEI is a hearing aid where either the receiver or 
the entire hearing aid is surgically inserted into the 
middle ear. The advantages of such an implant are two-
fold. First, if the ossicles can be driven directly, there 
may be improved sound quality, with no feedback. 
Second, a MEI may be completely implantable with 
no external components at all. Indeed, two manufac-
turers have now designed completely implantable 
middle ear devices. In addition, depending on the 
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MEI, if there is no device in the ear canal, there is no 
insertion loss with a net boost in high-frequency sound 
transmission2.
Direct drive, implantable middle ear hearing de-
vices represent a new category of hearing devices. 
Rather than delivering acoustic energy into the exter-
nal auditory canal (as with traditional hearing aid sys-
tems), direct drive MEI systems use mechanical vibra-
tions delivered directly to the ossicular chain, while 
leaving the ear canal completely open. One major ad-
vantage of direct drive devices is the ability to provide 
improved sound quality to hearing impaired subjects 
13. Patient reports of improved sound quality with di-
rect drive devices of various types have been published 
previously by many authors3-5. In a recently published 
report, patients using the Vibrant® Soundbridge™ 
MEI systems using the Floating Mass Transducer™ 
(FMT) have also reported improvements in overall 
sound quality, clearness of sound and tone, and im-
proved sound quality with respect to their own voice6.
Appropriate candidates for direct drive middle ear 
hearing devices include adults aged 18 years and older 
with moderate to severe sensorineural hearing loss. 
Candidates should have experience with traditional 
hearing aid fittings and should desire an alternative 
hearing system. Word recognition as determined un-
der headphones should be at least 50 percent correct in 
the designated ear. Normal middle ear function should 
be apparent based on clinical history, tympanometry 
and observation. The patient should be counseled re-
garding realistic expectations. Often, patients who are 
interested in seeking direct drive middle ear hearing 
devices have experienced dissatisfaction regarding 
sound quality of their own voice. Despite multiple of-
fice visits to their hearing healthcare professional, 
these individuals are unable to produce speech sounds 
that sound ‘normal’ or comfortable to them, and they 
are unable to overcome this obstacle. Additionally, 
some of the patients who have been successful with the 
direct drive middle ear hearing device have experi-
enced physical discomfort while wearing traditional 
hearing aids. Other commonalities across these pa-
tients include frustration with amplification secondary 
to multiple hearing aid repairs and multiple office vis-
its, cerumen issues relating to occluded hearing aid 
receivers, and potential cerumen impaction of the ex-
ternal auditory canal, inability to wear traditional 
hearing aids due to sensitive ear canal skin, exostosis, 
miscellaneous physical complaints related to the pres-
ence of a foreign object in the ear canal, and the in-
ability to overcome acoustic feedback issues with tra-
ditional amplification. Sound quality measures are dif-
ficult to grasp and quantify. Almost by definition, the 
word ‘quality’ implies a subjective measure7-9. There are 
several theoretical reasons why direct drive MEI hear-
ing devices might indeed produce better sound quality 
than conventional acoustic hearing aids. The theoreti-
cal issues which might impact qualitative judgments 
include increased high frequency gain (more high fre-
quency energy can be delivered via the Vibrant Sound-
bridge than would typically be anticipated using tradi-
tional hearing aid technology), improved signal cou-
pling (bypassing the tympanic membrane, yielding a 
potentially more efficient high frequency sound trans-
fer system, reduction in acoustic feedback because the 
signal is not acoustically delivered into the external 
auditory canal, less acoustic feedback is likely), no in-
sertion loss, no occlusion effect, and reduced distortion 
from external auditory canal resonances because the 
external auditory canal is not occluded while using di-
rect drive MEI systems2.
The first Food and Drug Administration (FDA) 
approval for a direct drive MEI system was granted on 
August 31, 2000. The Vibrant Soundbridge was shown 
to be safe and effective in clinical studies10. A review of 
81 patients, studied as part of the FDA approval pro-
cess, determined that the participants could hear as 
well with the device as with more traditional hearing 
aids (FDA, 2000). Fisch et al. report on the results in 
47 patients in their multi-center European clinical tri-
als. They found that the Vibrant Soundbridge could be 
used safely to treat moderate to severe sensorineural 
hearing loss. Additionally, they reported that changes 
in pre- versus postoperative hearing thresholds (under 
headphones) were clinically nonsignificant (within 5 
dB)8. Fraysse et al. have reported results in 25 patients 
using the Vibrant Soundbridge direct drive MEI sys-
tem. Objective and subjective tools were used to deter-
mine results. Their results indicated that no significant 
changes were recorded concerning the status of pre- 
versus postoperative hearing thresholds. These authors 
have also reported significant improvements in com-
munication across various listening situations while 
using the Vibrant Soundbridge, as compared to tradi-
tional (acoustic) hearing aid fittings in the majority of 
their patients11.
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The Vibrant Soundbridge Device
The Vibrant Soundbridge is a partially implantable 
hearing system for adults with mild to severe sensori-
neural hearing loss, as well as for persons with conduc-
tive and mixed hearing losses. It is implanted in the 
middle ear and mechanically vibrates the middle ear 
structures.
The Vibrant Soundbridge consists of two parts, an 
external portion and implanted portion12.
The external portion: Audio Processor
The externally worn Audio Processor (Fig. 1) is at-
tached to the patient’s head, behind the ear, by a mag-
net that is attracted to a magnet within the implanted 
Vibrating Ossicular Prosthesis (VORP) (Fig. 2). The 
Audio Processor includes a microphone to pick up 
sound from the environment, sound processing cir-
cuitry to modify the output signal to the patient’s spe-
cific requirements, a battery to power the device, and 
high-quality, fully digital signal processing. The Audio 
Processor is designed to have a battery life of approxi-
mately one week. The attractive features of the Vibrant 
Soundbridge are wearing comfort, as the ear canal re-
mains completely open and the Audio Processor is 
nicely hidden by hair. The Vibrant Soundbridge is ac-
tivated by fitting the Audio Processor13.
ductor link, and the innovative technology of the 
Floating Mass Transducer™ (FMT™). The signal 
from the Audio Processor is transmitted to the VORP 
and transformed into mechanical vibrations by the 
FMT. The VORP is implanted during a surgical pro-
cedure in which the FMT is attached to a vibratory 
structure of the ear. When activated, the FMT vibrates 
in a controlled manner, specific to each patient’s hear-
ing needs, causing the structure of the ear to vibrate. It 
conducts a wide frequency range up to 8000 Hz. The 
FMT is a totally enclosed transducer that uses inertial 
drive to impart mechanical vibrations directly to the 
vibrating structure of the middle ear, i.e. the ossicles. 
Although small in size, the mechanical energy that the 
FMT imparts to the vibratory structure can be compa-
rable to very high sound pressure levels. The FMT has 
been specifically designed to mimic the vibratory re-
sponses of the middle ear. It is capable of delivering 
mechanical stimulation to the middle ear throughout 
the entire speech frequency range of human ears. The 
FMT has two electromagnetic coils. The coils are 
wound around hermetically sealed titanium housing. 
Residing within the housing is a permanent magnet 
supported by a pair of springs. Electrical signal is 
 supplied to the coils, which in turn causes the magnet 
and the entire transducer to vibrate. The driving force 
of the transducer is imparted to both the ossicular 
chain and the driving mass through their mutual reac-
tion. This type of inertial drive transducer is referred to 
as a ‘Floating Mass Transducer’ or FMT. The trans-
ducer is the key component of the Vibrant Sound-
bridge10,14,15.
Fig. 1. Audio processor of the Vibrant Soundbridge.
The implanted portion: Vibrating Ossicular  
Prosthesis (VORP)
The implanted part of the Vibrant Soundbridge is 
called the Vibrating Ossicular Prosthesis (VORP) and 
consists of an internal coil, a magnet to hold the Audio 
Processor over the implant, a demodulator, the con-
Fig. 2. Vibrating ossicular prosthesis  
of the Vibrant Soundbridge.
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Selection Criteria
Selection criteria are sensorineural (Fig. 3), con-
ductive and mixed hearing losses (Fig. 4).
Sensorineural hearing loss
Conductive and mixed hearing losses
Fig. 3. Sensorineural hearing loss for the Vibrant 
Soundbridge implantation.
1. Air-conduction thresholds at or within the 
shaded region.
2. Normal middle ear function as shown by audio-
metric thresholds, tympanometry and acoustic 
reflexes.
3. Speech understanding of at least 50% on an 
open-set word test; 
-  at the most comfortable listening level using 
head phones, or
-  at 65 dB SPL in the free field using hearing 
aid(s).
4. Stable hearing loss. Patient should be experi-
enced with hearing aids.
5. No skin conditions preventing attachment of 
the Audio Processor.
6. Realistic expectations.
7. Absence of retrocochlear and central auditory 
disorders.
8. 18 years of age or older16-18.
Fig. 4. Conductive and mixed hearing losses  
for the Vibrant Soundbridge implantation.
1. Bone-conduction thresholds at or within the 
shaded region.
2. Ear anatomy allows positioning of the FMT in 
contact with a suitable vibratory structure of the 
ear.
3. Absence of active middle ear infection and/or 
chronic fluid in the ear.
4. Stable bone conduction thresholds.
5. No skin conditions preventing attachment of 
the Audio Processor.
6. Realistic expectations.
7. Absence of retrocochlear and central auditory 
disorders.
8. 18 years of age or older19-21.
Surgery
There are two common surgical routes to access the 
middle ear:
1. the facial recess route via mastoidectomy and 
posterior tympanotomy (Fig. 5), and
2. the transmeatal route via the ear canal. Sur-
geons determine which route to use from the 
medical status of the patient’s ear. Surgeons 
may also combine the two. It is possible to ei-
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ther attach the FMT to the incus (Fig. 6)22, or 
to place it in the round window niche23.
Surgery takes about 2 to 2.5 hours and is performed 
either on an outpatient or inpatient basis. As with all 
surgical procedures, the physician must fully assess the 
potential risks and benefits for the patient prior to the 
decision to implant the Vibrant Soundbridge. The 
physician must exercise medical judgment and con-
sider the patient’s complete medical history. Four to 
eight weeks after surgery and healing, the surgeon 
medically evaluates the patient, and an audiologist 
programs the Audio Processor to activate the Vibrant 
Soundbridge. The patient typically wears the device 
for several hours a day, or all day, immediately after 
activation24.
Programming the Audio Processor
Because of variations in skin flap thickness, differ-
ent magnet strengths are available. The Audio Proces-
sor should hold firmly onto the head without creating a 
pressure point. The Vibrant Soundbridge uses Siemens 
Connexx software along with the SYMFIT proprietary 
database. The software features eight channels for inde-
pendent gain adjustment and four individual bands of 
compression. The Vibrant Soundbridge is activated 
when the Audio Processor is placed over the internal 
coil of the implant and the battery compartment door 
is closed. The Audio Processor has no user controls. To 
extend battery life, the battery door should be opened 
whenever the Audio Processor is not in use. This dis-
connects the battery from the Audio Processor and 
shuts off the Audio Processor. The Audio Processor is 
designed to have a battery life of approximately one 
week. This is based on an average duration of use of 16 
hours a day at an average volume level. The battery life 
of the Audio Processor may vary depending on pro-
grammed settings, environment, and duration of use2.
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Sažetak
AKTIVNI SLUŠNI IMPLANTAT SREDNJEGA UHA VIBRANT SOUNDBRIDGE
A. Pegan, M. Ries, J. Ajduk, V. Bedeković, M. Ivkić i R. Trotić
Vibrant Soundbridge (VSB) predstavlja nov pristup poboljšanju oštećenog sluha aktivnim ugradbenim uređajem za 
srednje uho. Taj uređaj zaobilazi zvukovod i bubnjić, za razliku od standardnih slušnih pomagala kod kojih povećani volumen 
zvuka ide kroz njih i izaziva direktne vibracije lanca slušnih košćica. Zahvaljujući svom dizajnu nijedan dio VSB-a nije u 
zvukovodu. VSB je odobrila FDA kao siguran postupak u liječenju odraslih osoba koje imaju zamjedbeno, provodno ili mje-
šovito oštećenje sluha i koje žele čuti bolje nego sa standardnim slušnim pomagalima. Ovaj rad je pregled djelovanja aktivnog 
ugradbenog implantata srednjega uha VSB-a koji je ugrađen na Klinici za otorinolaringologiju i kirurgiju glave i vrata KBC-
a Sestre milosrdnice, Referentnom centru Ministarstva zdravlja za kohlearnu implantaciju i kirurgiju nagluhosti i gluhoće.
Ključne riječi: Sluh; Slušna pomagala; Sluh, gubitak, neurosenzorni; Sluh, gubitak, mješovit provodno-neurosenzorni; Hrvatska
